Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue

Go back to Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 41.96 -0.96 (2.24%)
Previous Close $42.92    52 Week High $26.84 
Open $42.89    52 Week Low $9.51 
Day High $42.89    P/E N/A 
Day Low $41.60    EPS $-2.62 
Volume 346,058